投資評等
最後更新日期：2024/4/26
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/6/17 | Stifel | Hold >> Buy | 30 |
| 2014/4/15 | Argus | Hold >> Buy | 28 |
| 2013/1/8 | Deutsche Bank | Hold >> Buy | $11 >> $15 |
| 2012/7/24 | Standpoint Research | Hold >> Buy | 11 |
| 2012/4/4 | Barclays | Equal Weight >> Overweight | $11 >> $13 |
| 2011/5/9 | Dahlman Rose | Hold >> Buy | 15 |
| 2011/3/11 | CRT Capital | Hold >> Buy | |
| 2010/4/19 | JP Morgan | Underweight >> Overweight | $12 >> $17 |
| 2009/9/23 | Argus | Sell >> Buy | 11 |
| 2006/10/24 | Calyon Securities | Neutral Add | 18 |
| 2006/8/15 | Citigroup | Hold Buy | |
| 2006/7/27 | Matrix Research | Hold Buy | |
| 2006/5/2 | JP Morgan | Neutral Overweight | |
| 2006/2/3 | Matrix Research | Hold Buy | |
| 2005/9/22 | Fulcrum | Neutral->Buy | 20 |
| 2005/9/21 | JP Morgan | Underweight->Overweight | |
| 2005/1/18 | Smith Barney Citigroup | Hold->Buy | |
| 2005/1/7 | BB&T Capital Mkts | Hold->Buy | 20 |
| 2004/11/24 | UBS | Reduce->Buy | |
| 2004/3/18 | UBS | Reduce->Neutral | 14 |
| 2004/2/12 | Raymond James | Mkt Perform->Outperform | 18 |
| 2003/12/10 | Deutsche Securities | Hold->Buy | 20 |
| 2003/12/2 | Blaylock & Partners | Hold->Buy | 22 |
| 2003/10/21 | Prudential | Neutral -> Overweight | 24 |
| 2003/9/10 | Morgan Stanley | Equal-weight -> Overweight | 22 |
| 2003/9/10 | Morgan Stanley | Equal-weight -> Overweight | 22 |
| 2003/1/23 | CSFB | Neutral -> Outperform | |
| 2002/10/1 | Lehman Brothers | Equal-weight -> Overweight | |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2015/5/20 | Buckingham Research | Buy >> Neutral | |
| 2012/12/14 | Standpoint Research | Buy >> Hold | |
| 2009/10/19 | JP Morgan | Neutral >> Underweight | $11.50 >> $6.50 |
| 2009/8/10 | Standpoint Research | Buy >> Hold | |
| 2009/7/6 | Argus | Hold >> Sell | |
| 2007/10/1 | Citigroup | Buy Hold | |
| 2007/4/20 | HSBC Securities | Overweight Neutral | |
| 2005/10/25 | JP Morgan | Overweight->Neutral | |
| 2005/5/19 | Prudential | Overweight->Neutral | |
| 2003/12/4 | Raymond James | Outperform->Mkt Perform | |
| 2003/7/11 | UBS | Neutral -> Reduce | |
| 2003/2/3 | Raymond James | Strong Buy -> Outperform | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2011/11/14 | Maxim Group | Hold | |
| 2010/7/16 | Dahlman Rose | Hold | |
| 2010/6/14 | Deutsche Bank | Buy | 15 |
| 2009/7/8 | Next Generation | Neutral | 7 |
| 2006/11/29 | Goldman Sachs | Sell | |
| 2006/7/21 | Matrix Research | Hold | |
| 2006/6/22 | UBS | Buy | |
| 2005/9/21 | Citigroup | Buy | 16.5 |
| 2005/1/14 | Prudential | Overweight | 22 |
| 2004/4/6 | Smith Barney Citigroup | Hold | 17 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2002/11/1 | Morgan Stanley | Equal-weight | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2015/12/21 | Deutsche Bank | Buy | $54 >> $57 |
| 2015/6/9 | Cowen | Outperform | $55 >> $45 |
| 2015/3/16 | Argus | Buy | $46 >> $56 |
| 2014/12/15 | Deutsche Bank | Buy | $46 >> $55 |
| 2014/12/10 | Imperial Capital | Outperform | $48 >> $53 |
| 2014/11/11 | UBS | Buy | $38 >> $44 |
| 2014/9/9 | Cowen | Outperform | $32 >> $39 |
| 2014/4/4 | Barclays | Overweight | $26 >> $28 |
| 2014/2/4 | Barclays | Overweight | $22 >> $26 |
| 2012/9/14 | Imperial Capital | In-line | $10 >> $8 |